What began as a handful of students planning a Relay for Life two decades ago has grown into a tradition of cardiac and cancer awareness at Stony Brook.
Stony Brook University and Stony Brook Medicine helped transform the streets of Port Jefferson into a winter gallery for the Seventh Annual Ice Festival.
Stony Brook Heart Institute’s Center for Advanced Lipid Management has achieved a historic global milestone, becoming the first center in the world to administer a commercial dose of plozasiran, the newly approved RNA...
For the estimated 1.6 million Americans diagnosed with symptomatic tricuspid valve regurgitation each year, a significant advancement in treatment is now available on Long Island. With the launch of the new...
Stony Brook Medicine is the first on Long Island — and one of a select number of healthcare systems nationwide — to implement an artificial intelligence (AI) technology, HeartFlow Plaque Analysis™, to enable its...
Two Stony Brook Heart Institute (SBHI) cardiothoracic surgeons have been inducted into the American Association for Thoracic Surgery (AATS). Member inductions are reserved for a limited number of select physicians each...
Among first in the nation to perform ultrasound renal denervation The Stony Brook Heart Institute at Stony Brook University Hospital is expanding its advanced treatment options for those with high blood pressure. The...
Longest continuously running VAD program on Long Island In 2010, Stony Brook Heart Institute’s Ventricular Assist Device (VAD) program was established on Long Island to implant this life saving device. A VAD, also often...
Stony Brook Medicine’s Cardio-Oncology program is the first on Long Island to be recognized as an IC-OS Center of Excellence and awarded an IC-OS Gold Medal by the International Cardio-Oncology Society (IC-OS). An IC-OS...
Physicians at the Stony Brook Heart Institute Valve Center have expanded the array of transcatheter aortic valve replacement (TAVR) approaches with two innovative techniques for treating patients with severe aortic...
The PerQseal® device is the first sutureless, fully absorbable intravascular 'patch' that seals an artery from the inside after heart valve repair or replacement.
Throughout his career — in engineering, heavy construction and government — Ambassador Charles A. Gargano played a central role in protecting the beating heart of New York’s economy. On May 29, Stony Brook University...